$SDEV 4/A SEC Filings

Filed On	Filing
30 Apr 2026	Form 4/A: Kazley Michael John, Director Acquired 11,332,020 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) · Received 11,361,216 shares by conversion
30 Apr 2026	Form 4/A: Framework Ventures Iv L.p., 10% owner and 4 others Acquired 11,332,020 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) · Received 11,361,216 shares by conversion
30 Apr 2026	Form 4/A: R01 Fund Lp, 10% owner and 3 others Acquired 11,332,020 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) · Received 11,361,216 shares by conversion
22 Oct 2025	Form 4/A: Framework Ventures Iv L.p., 10% owner and 4 others Acquired 220,663 Series D Non-Voting Convertible Preferred Stock (Other Transaction) · Acquired 134,375 Series E Non-Voting Convertible Preferred Stock (Other Transaction)
05 Dec 2022	Form 4/A: Kunin Audrey, Chief Product Officer Sold 5,960 shares ($12.5K)
05 Dec 2022	Form 4/A: Kunin Jeffrey, President, DERMAdoctor, LLC Sold 5,960 shares ($12.5K)
28 Oct 2019	Form 4/A: Raleigh Jason Philip, Interim CFO and Treasurer Received 23,405 shares as a grant or award ($51.5K) · Sold 23,405 shares ($70.2K) · Exercised 23,405 Stock Option (right to buy) · 3 more
28 Oct 2019	Form 4/A: Hall Justin, Interim President & CEO and GC Received 47,500 shares as a grant or award ($96K) · Sold 47,500 shares ($144K) · Exercised 47,500 Stock Option (right to buy)
19 Jan 2018	Form 4/A: Ma Yonghao, Director Granted 20,326 stock option (right to buy)
04 Oct 2016	Form 4/A: Zavodnick Todd Erik, Director Granted 247 Stock Option (right to buy)
30 Apr 2015	Form 4/A: Hoon Russell A., Senior Vice President Received 4,515 shares by conversion
01 Nov 2012	Form 4/A: Najafi Ramin, Director Granted 65,000 Option (right to buy)
01 Nov 2012	Form 4/A: Khosrovi Behzad, SVP Product Development Granted 25,000 Option (right to buy)
01 Nov 2012	Form 4/A: Wu Roy J, SVP Bus & Corp Development Granted 25,000 Option (right to buy)
01 Nov 2012	Form 4/A: Stroman David W., SVP, Ophthalmic Product Devt. Granted 25,000 Option (right to buy)
01 Nov 2012	Form 4/A: Paulson Thomas J, CFO Granted 25,000 Option (right to buy)
01 Feb 2011	Form 4/A: Khosrovi Behzad, SVP Product Development & CAO Granted 35,400 Option (right to buy)
01 Feb 2011	Form 4/A: O'Reilly John James, Director Granted 44,400 Option (Right to buy)
01 Feb 2011	Form 4/A: Paulson Thomas J, CFO Granted 44,400 Option (right to buy)
01 Feb 2011	Form 4/A: Scott Colin, VP, Clinical Research and Dev Granted 35,400 Option (right to buy)

Comments